144 related articles for article (PubMed ID: 3182443)
1. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection.
Couvreur J; Desmonts G; Thulliez P
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():193-200. PubMed ID: 3182443
[TBL] [Abstract][Full Text] [Related]
2. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of congenital toxoplasmosis].
Russo M; Galanti B
Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535
[TBL] [Abstract][Full Text] [Related]
4. Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.
Valentini P; Buonsenso D; Barone G; Serranti D; Calzedda R; Ceccarelli M; Speziale D; Ricci R; Masini L
J Perinatol; 2015 Feb; 35(2):90-4. PubMed ID: 25211284
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
[TBL] [Abstract][Full Text] [Related]
6. Role of spiramycin in prevention of fetal toxoplasmosis.
Avci ME; Arslan F; Çiftçi Ş; Ekiz A; Tüten A; Yildirim G; Madazli R
J Matern Fetal Neonatal Med; 2016; 29(13):2073-6. PubMed ID: 26365472
[TBL] [Abstract][Full Text] [Related]
7. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone.
Vergani P; Ghidini A; Ceruti P; Strobelt N; Spelta A; Zapparoli B; Rescaldani R
Am J Reprod Immunol; 1998 May; 39(5):335-40. PubMed ID: 9602252
[TBL] [Abstract][Full Text] [Related]
8. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine.
Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
Fetal Diagn Ther; 1993; 8(1):45-50. PubMed ID: 8452648
[TBL] [Abstract][Full Text] [Related]
9. Congenital toxoplasmosis and prenatal care state programs.
Avelino MM; Amaral WN; Rodrigues IM; Rassi AR; Gomes MB; Costa TL; Castro AM
BMC Infect Dis; 2014 Jan; 14():33. PubMed ID: 24438336
[TBL] [Abstract][Full Text] [Related]
10. Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid.
Gratzl R; Sodeck G; Platzer P; Jäger W; Graf J; Pollak A; Thalhammer T
Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):12-6. PubMed ID: 11913495
[TBL] [Abstract][Full Text] [Related]
11. [Fetomaternal therapeutic follow-up of spiramycin during pregnancy].
Forestier F; Daffos F; Rainaut M; Desnottes JF; Gaschard JC
Arch Fr Pediatr; 1987; 44(7):539-44. PubMed ID: 3426376
[TBL] [Abstract][Full Text] [Related]
12. [Effect of antenatal spiramycin treatment on the frequency of retinochoroiditis due to congenital toxoplasmosis in a Colombian cohort].
Zuluaga LM; Hernández JC; Castaño CF; Donado JH
Biomedica; 2017 Apr; 37(0):86-91. PubMed ID: 28527270
[TBL] [Abstract][Full Text] [Related]
13. The placenta: a main role in congenital toxoplasmosis?
Robert-Gangneux F; Murat JB; Fricker-Hidalgo H; Brenier-Pinchart MP; Gangneux JP; Pelloux H
Trends Parasitol; 2011 Dec; 27(12):530-6. PubMed ID: 22079164
[TBL] [Abstract][Full Text] [Related]
14. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii.
Gilbert R; Gras L;
BJOG; 2003 Feb; 110(2):112-20. PubMed ID: 12618153
[TBL] [Abstract][Full Text] [Related]
15. The prevention of congenital toxoplasmosis using a combination of Spiramycin and Cotrimoxazole: The long-time experience of a tertiary referral centre.
De Santis M; Tartaglia S; Apicella M; Visconti D; Noia G; Valentini P; Lanzone A; Santangelo R; Masini L
Trop Med Int Health; 2024 Jun; ():. PubMed ID: 38842439
[TBL] [Abstract][Full Text] [Related]
16. Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis.
Fricker-Hidalgo H; Brenier-Pinchart MP; Schaal JP; Equy V; Bost-Bru C; Pelloux H
Pediatr Infect Dis J; 2007 Sep; 26(9):845-6. PubMed ID: 17721384
[TBL] [Abstract][Full Text] [Related]
17. Comparison of adverse reactions of spiramycin versus pyrimethamine/sulfadiazine treatment of toxoplasmosis in pregnancy: is spiramycin really the drug of choice for unproven infection of the fetus?
Prasil P; Sleha R; Kacerovsky M; Bostik P
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2215377. PubMed ID: 37217458
[TBL] [Abstract][Full Text] [Related]
18. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.
Daffos F; Forestier F; Capella-Pavlovsky M; Thulliez P; Aufrant C; Valenti D; Cox WL
N Engl J Med; 1988 Feb; 318(5):271-5. PubMed ID: 3336419
[TBL] [Abstract][Full Text] [Related]
19. Treatment of toxoplasmosis in the pregnant mother and newborn child.
Stray-Pedersen B
Scand J Infect Dis Suppl; 1992; 84():23-31. PubMed ID: 1290070
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasmosis in pregnancy.
Stray-Pedersen B
Baillieres Clin Obstet Gynaecol; 1993 Mar; 7(1):107-37. PubMed ID: 8513640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
